TSHA - Taysha Gene Therapies, Inc.
NEXT EARNINGS:
Feb 25, 2026
(today)
EPS Est: $-0.11
|
Rev Est: $1.9M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$11.13
DETAILS
HIGH:
$13.00
LOW:
$8.00
MEDIAN:
$11.00
CONSENSUS:
$11.13
UPSIDE:
127.61%
Market Cap:
1.17B
Volume:
1,513,021
Avg Volume:
2,970,066
52 Week Range:
1.05-6.02
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.99
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
73
IPO Date:
2020-09-24
EPS (TTM):
-0.36
P/E Ratio:
-4.85
Revenue (TTM):
8.33M
Total Assets:
160.36M
Total Debt:
63.18M
Cash & Equiv:
139.04M
Rev Growth (5Y):
82.5%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-66.5%
Debt/Equity:
0.88
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-04 | $-0.09 | $-0.09 | 0.0% | — | $1.9M | — |
| 2025-08-12 | $-0.09 | $-0.07 | -28.6% | $2.0M | $1.7M | +14.9% |
| 2025-05-15 | $-0.08 | $-0.08 | 0.0% | $2.3M | $1.1M | +112.3% |
| 2025-02-26 | $-0.07 | $-0.08 | +12.5% | $2.0M | $2.1M | -1.5% |
| 2024-11-13 | $-0.09 | $-0.08 | -12.5% | $1.8M | $2.1M | -12.9% |
| 2024-08-12 | $-0.09 | $-0.10 | +10.0% | $1.1M | $2.7M | -58.2% |
| 2024-05-14 | $-0.10 | $-0.11 | +9.1% | $3.4M | $2.6M | +33.2% |
| 2024-03-19 | $0.35 | $-0.09 | +488.9% | $3.6M | $2.6M | +36.0% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 8.33M | 15.45M | 2.50M | 0 | 0 | 0 |
| Net Income | (89.30M) | (111.57M) | (166.01M) | (174.52M) | (43.00M) | (1.11M) |
| EPS | -0.36 | -0.96 | -3.78 | -4.64 | -3.40 | -0.03 |
| Total Assets | 160.36M | 172.73M | 126.28M | 213.96M | 258.88M | 15,000 |
| Total Debt | 63.18M | 61.11M | 59.93M | 63.09M | 0 | 0 |
| Cash & Equivalents | 139.04M | 143.94M | 87.88M | 149.10M | 251.25M | 0 |
| Operating Cash Flow | (81.22M) | (73.02M) | (88.39M) | (117.04M) | (30.73M) | 135,000 |
| Free Cash Flow | (81.60M) | (80.39M) | (113.26M) | (138.60M) | (39.81M) | 135,000 |
| FCF per Share | -0.33 | -0.69 | -2.58 | -3.68 | -2.25 | 0.00 |
| Book Value | 71.53M | 74.94M | 949,000 | 95.38M | 251.30M | (135,000) |
| Cash & ST Investments | 139.04M | 143.94M | 87.88M | 149.10M | 251.25M | 0 |
| ROC Equity | -1.25 | -1.49 | -174.94 | -1.83 | -0.17 | N/A |